about us
Curiosity, rigour and courage, in service of better health.
We bring strategy, science and systems thinking together to help health organisations turn complexity into progress.
one health
One planet. One health.
We align with the One Health vision advanced by WHO: the health of people, animals, plants and ecosystems is interdependent. It is not a niche idea. It is a practical framework for prevention.
People.
Fair access to prevention, diagnosis, care and trustworthy information.
Animals.
Human and animal health share risks, so prevention has to look at both.
Plants.
The food we grow shapes the health we have, long before anyone sees a clinician.
Ecosystems.
From land to the deep ocean, the environments we protect protect us back.
Healthy ecosystems are the first line of prevention.
Resilient health systems do more than treat disease. They anticipate it, reduce exposure to risk and support healthier relationships between communities and the natural world. Prevention is not only smart, it is more humane.
about us
Scientists, strategists and systems thinkers.
We help health organisations turn complexity into progress. We value questions as much as answers, because innovation depends on curiosity, rigour and courage.
We also know fresh thinking doesn’t come from a tired brain. So our team unapologetically protects its downtime, whether that means chasing after kids, walking pets, dabbling in art, building cars or doing absolutely nothing at all.
our founder & ceo
Evie Maifoshie
Evie brings more than 15 years of experience across the pharmaceutical industry and health start-ups, helping organisations turn complex science into products, partnerships and better patient outcomes. She completed her PhD from Imperial College London in Clinical Cardiovascular Science, where she worked on a new therapeutic modality for cardiovascular conditions. She holds an EMBA from the Quantic School of Business & Technology with focus on Strategy and Entrepreneurship. She moved to GSK, leading drug discovery programmes and working across disciplines at the interface of R&D and business. At Novartis, as an Oncology Health Solutions Specialist, she worked between market access and reimbursement on pre-launch drug strategies. Her experience spans a wide range of therapeutic areas, from rare diseases at the Weatherall Institute of Molecular Medicine in Oxford to colon cancer, breast cancer and respiratory conditions. She is the founder of mirare health (Cyprus) and MiRare Therapeutics (UK), both with a focus on building health equity with patient-centric technology and the use of trustworthy and responsible AI in diagnostics and drug discovery.

our thesis
We build with intention around three challenges.
Health equity begins with truth.
Everyone deserves to reach their highest health potential. We work on the avoidable gaps that income, geography, race or disability create, starting with those facing the greatest barriers.
Health starts before illness.
Health is shaped long before someone sees a clinician. We help systems support people early, and where prevention isn’t possible, we push for earlier detection and better care.
Misinformation blocks progress.
Misinformation slows care, weakens trust and puts people at risk. Progress depends on clear, credible, evidence-based communication.
focus areas
Where we work.
From the brain to the deep ocean, we focus on health challenges where research, technology and people have to move together.
- Mental health
- Digital therapeutics & preventive health
- Healthcare innovation in the era of AI
- Next-generation cancer care
- Rare diseases
- Empowering patients
- From lab to market
- Skills for the future of digital health
- Marine & ecosystem health
- EU grants & consortia
- Humane technologies
- Evidence-based advocacy
- Citizen science
let’s talk
Ready to dive in?
You see what we did there? Our name combines “innov” from innovation with “vethos”, inspired by the Greek word for deep ocean (βάθος).